These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33303833)

  • 1. Comparison of the amniotic fluid and fetal urine peptidome for biomarker discovery in renal developmental disease.
    Fédou C; Breuil B; Golovko I; Decramer S; Magalhães P; Muller F; Dreux S; Zürbig P; Klein J; Schanstra JP; Buffin-Meyer B
    Sci Rep; 2020 Dec; 10(1):21706. PubMed ID: 33303833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of the fetal urinary metabolome and peptidome for the prediction of postnatal renal outcome in fetuses with PUV.
    Buffin-Meyer B; Klein J; Breuil B; Muller F; Moulos P; Groussolles M; Bouali O; Bascands JL; Decramer S; Schanstra JP
    J Proteomics; 2018 Jul; 184():1-9. PubMed ID: 29929039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGF-I, IGF-II, IGF binding protein 1, and C-peptide in second trimester amniotic fluid are dependent on gestational age but do not predict weight at birth.
    Verhaeghe J; Coopmans W; van Herck E; van Schoubroeck D; Deprest JA; Witters I
    Pediatr Res; 1999 Jul; 46(1):101-8. PubMed ID: 10400142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal urinary peptides to predict postnatal outcome of renal disease in fetuses with posterior urethral valves (PUV).
    Klein J; Lacroix C; Caubet C; Siwy J; Zürbig P; Dakna M; Muller F; Breuil B; Stalmach A; Mullen W; Mischak H; Bandin F; Monsarrat B; Bascands JL; Decramer S; Schanstra JP
    Sci Transl Med; 2013 Aug; 5(198):198ra106. PubMed ID: 23946195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-free fetal DNA in amniotic fluid: unique fragmentation signatures in euploid and aneuploid fetuses.
    Lapaire O; Bianchi DW; Peter I; O'Brien B; Stroh H; Cowan JM; Tantravahi U; Johnson KL
    Clin Chem; 2007 Mar; 53(3):405-11. PubMed ID: 17259241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UPLC-MS metabolic profiling of second trimester amniotic fluid and maternal urine and comparison with NMR spectral profiling for the identification of pregnancy disorder biomarkers.
    Graça G; Goodfellow BJ; Barros AS; Diaz S; Duarte IF; Spagou K; Veselkov K; Want EJ; Lindon JC; Carreira IM; Galhano E; Pita C; Gil AM
    Mol Biosyst; 2012 Apr; 8(4):1243-54. PubMed ID: 22294348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of adiponectin and placental growth factor in amniotic fluid with second trimester fetal growth.
    Kalampokas E; Vrachnis N; Samoli E; Rizos D; Iliodromiti Z; Sifakis S; Kalampokas T; Vitoratos N; Creatsas G; Botsis D
    In Vivo; 2012; 26(2):327-33. PubMed ID: 22351679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amniotic fluid peptides predict postnatal kidney survival in developmental kidney disease.
    Klein J; Buffin-Meyer B; Boizard F; Moussaoui N; Lescat O; Breuil B; Fedou C; Feuillet G; Casemayou A; Neau E; Hindryckx A; Decatte L; Levtchenko E; Raaijmakers A; Vayssière C; Goua V; Lucas C; Perrotin F; Cloarec S; Benachi A; Manca-Pellissier MC; Delmas HL; Bessenay L; Le Vaillant C; Allain-Launay E; Gondry J; Boudailliez B; Simon E; Prieur F; Lavocat MP; Saliou AH; De Parscau L; Bidat L; Noel C; Floch C; Bourdat-Michel G; Favre R; Weingertner AS; Oury JF; Baudouin V; Bory JP; Pietrement C; Fiorenza M; Massardier J; Kessler S; Lounis N; Auriol FC; Marcorelles P; Collardeau-Frachon S; Zürbig P; Mischak H; Magalhães P; Batut J; Blader P; Saulnier Blache JS; Bascands JL; Schaefer F; Decramer S; Schanstra JP;
    Kidney Int; 2021 Mar; 99(3):737-749. PubMed ID: 32750455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amniotic Fluid and Maternal Serum Metabolic Signatures in the Second Trimester Associated with Preterm Delivery.
    Virgiliou C; Gika HG; Witting M; Bletsou AA; Athanasiadis A; Zafrakas M; Thomaidis NS; Raikos N; Makrydimas G; Theodoridis GA
    J Proteome Res; 2017 Feb; 16(2):898-910. PubMed ID: 28067049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The presence of human mesenchymal stem cells of renal origin in amniotic fluid increases with gestational time.
    Rahman MS; Spitzhorn LS; Wruck W; Hagenbeck C; Balan P; Graffmann N; Bohndorf M; Ncube A; Guillot PV; Fehm T; Adjaye J
    Stem Cell Res Ther; 2018 Apr; 9(1):113. PubMed ID: 29695308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of fetuses with lower urinary tract obstruction and normal amniotic fluid volume in second trimester of pregnancy.
    Nassr AA; Shamshirsaz AA; Erfani H; Espinoza J; Sanz Cortes M; Koh CJ; Roth DR; Angelo JR; Mandy GT; Braun MC; Ruano R; Belfort MA
    Ultrasound Obstet Gynecol; 2019 Oct; 54(4):500-505. PubMed ID: 30977189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the cell-free amniotic fluid transcriptome expressed during the euploid mid-trimester of pregnancy.
    Jung YW; Shim SS; Park JE; Sung SR; Shim SH; Park HR; Cha DH
    Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():94-8. PubMed ID: 27261819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second trimester amniotic fluid glucose, uric acid, phosphate, potassium, and sodium concentrations in relation to maternal pre-pregnancy BMI and birth weight centiles.
    Fotiou M; Michaelidou AM; Athanasiadis AP; Menexes G; Symeonidou M; Koulourida V; Ganidou M; Theodoridis TD; Tarlatzis BC
    J Matern Fetal Neonatal Med; 2015 May; 28(8):910-5. PubMed ID: 25046579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein analysis in amniotic fluid and fetal urine for the assessment of fetal renal function and dysfunction.
    Burghard R; Gordjani N; Leititis J; Bald R
    Fetal Ther; 1987; 2(4):188-96. PubMed ID: 2474234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Urine and Plasma Peptidome Indicates Selectivity in Renal Peptide Handling.
    Magalhães P; Pontillo C; Pejchinovski M; Siwy J; Krochmal M; Makridakis M; Carrick E; Klein J; Mullen W; Jankowski J; Vlahou A; Mischak H; Schanstra JP; Zürbig P; Pape L
    Proteomics Clin Appl; 2018 Sep; 12(5):e1700163. PubMed ID: 29611317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptidome analysis of amniotic fluid from pregnancies with preeclampsia.
    Qian Y; Zhang L; Rui C; Ding H; Mao P; Ruan H; Jia R
    Mol Med Rep; 2017 Nov; 16(5):7337-7344. PubMed ID: 28944906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and immunochemical identification of the fetal polypeptides of human amniotic fluid during the second trimester of pregnancy.
    Prado VF; Reis DD; Pena SD
    Braz J Med Biol Res; 1990; 23(2):121-31. PubMed ID: 2207440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amniotic fluid prealbumin as a potential marker of fetal abnormalities.
    Lolis D; Georgiou I; Loizou P; Makrydimas G; Bairaktari E; Tsolas O
    Gynecol Obstet Invest; 1995; 40(4):231-5. PubMed ID: 8586303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Symptomatic Fetuses Infected with Cytomegalovirus Using Amniotic Fluid Peptide Biomarkers.
    Desveaux C; Klein J; Leruez-Ville M; Ramirez-Torres A; Lacroix C; Breuil B; Froment C; Bascands JL; Schanstra JP; Ville Y
    PLoS Pathog; 2016 Jan; 12(1):e1005395. PubMed ID: 26808779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between markers of DNA and lipid oxidative damage in maternal and fetoplacental compartment in the mid-trimester of pregnancy.
    Rejc B; Karas-Kuželički N; Osredkar J; Geršak K
    J Perinat Med; 2017 May; 45(4):413-419. PubMed ID: 27049611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.